Neurocentrx Pharma Pty Ltd
1 clinical trials · Sponsor
◉ Watch Neurocentrx Pharma Pty Ltd
| Record | Firm | Date |
|---|---|---|
| Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression (NCT07644767) | Neurocentrx Pharma Pty Ltd | 2026-10-30 |
Track Neurocentrx Pharma Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.